Search
for
Sort by
Research 781–810 of 905
- [Clinical significance of testosterone and dihydrotestosterone metabolism in women].
- [Hyperandrogenism and pilosebaceous follicles].
- [Usefulness and limitations of the evaluation of sex-hormone-binding globulin in women with a female pattern of androgen-induced baldness].
- [Hirsutism].
- [Treatment of moderately severe virilism of women with Diane and Androcur 10].
- Effects of cyproterone and tamoxifen upon the hair waves in mice.
- [Anti-androgens. Their use in dermatology].
- [Dermatologic indications for anti-androgenic treatment].
- [Reactions and side effects of ovulation inhibitors on the skin].
- [Systematic treatment with sex hormones in dermatology].
- Prevalence and Clinical Characteristics of Androgenetic Alopecia in Nepalese Patients: A Cross-sectional Observational Study
- Systemic therapy of androgenic alopecia
- [Analysis of steroids and binding proteins in the blood of women with androgenetic alopecia].
- [Endocrine constellation in androgenetic alopecia in the female].
- Effects of mitotane treatment on human steroid metabolism: implications for patient management
- The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial
- Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development
- Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study
- 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013
- Progestogens with Antiandrogenic Properties
- Androgenetic Alopecia: An Update of Treatment Options
- Safety of testosterone treatment in postmenopausal women
- Pharmacologic interventions in aging hair
- Sex hormones and acne
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- Female pattern hair loss: current treatment concepts.
- Female pattern alopecia: current perspectives